Looming competition from the east
29/11/19 -"A number of initiatives taken by the Chinese government to strengthen its pharmaceutical sector have started to bear fruit – Biogene’s ‘zanubrutinib’ became the first innovative drug by a Chinese ..."
Pages
70
Language
English
Published on
29/11/19
You may also be interested by these reports :
11/12/19
Novozymes reported soft Q3 19 numbers – missing estimates. Sales came in at DKK3,704m, up 1% on organic basis – driven by Household and Agriculture & ...
11/12/19
Following safety concerns, two clinical trials evaluating palovarotene for the treatment of rare bone disorders have been placed on partial hold (for ...
29/11/19
A number of initiatives taken by the Chinese government to strengthen its pharmaceutical sector have started to bear fruit – Biogene’s ‘zanubrutinib’ ...
19/11/19
Days after we pitched for Sanofi (Reduce, France) in July 2019, the French pharma giant took an impairment charge of €1.8bn, mainly related to its ...